Profile
| Metric | Value |
|---|---|
| Full Name | Oramed Pharmaceuticals Inc. |
| Ticker | NASDAQ: ORMP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | oramed.com |
| Employees | 13 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $3.68 | |
| Price, 1D Change | -0.27% | |
| $146M | ||
| 6.79% | ||
| 3.67 | ||
| 0.55 | ||
| $0 | ||
| Revenue, 1Y Change | -100.00% | |
| -$0.47 | ||
| EPS, 1Y Change | -442.73% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.25 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.47 | ||
| EPS Estimate | $1.29 | |
| EPS Est. Change | +376.35% | |
| $0.00 | ||
| Revenue Estimate | $2.00M | |
| Revenue Est. Change | - | |
| Current Price | $3.68 | |
| Price Target | - | $3.25 |
| Price Tgt. Change | - | -11.68% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.31 | $0.14 | +143.94% | |
| $0.17 | -$0.47 | -374.59% | |
| $1.29 | N/A | +376.35% | |
| - | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.34M | $1.34M | 0.00% | |
| - | $0.00 | - | |
| $2.00M | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $3.68 | |
| $2.39 | ||
| SMA 200 vs Price | -35.04% | |
| $2.85 | ||
| SMA 50 vs Price | -22.46% | |
| 0.55 | ||
| $0.20 | ||
| 74.69 | ||
| 53.28% | ||
| 51.05% |
Dividends
| Metric | Date | Value |
|---|---|---|
| $0.25 | ||
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.47 | ||
| -$193.00K | ||
| - | ||
| -$12.78M | ||
| - | ||
| -$19.10M | ||
| - | ||
| -$12.59M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 25.19 | ||
| 25.19 | ||
| - | ||
| - | ||
| 8.05 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 3.67 | ||
| 73.24 | ||
| 0.72 | ||
| -0.98 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $146.26M | ||
| $141.93M | ||
| $155.28M | ||
| $143.22M | ||
| $9.93M | ||
| $5.69M | ||
| $372.00K | ||
| $216.00K | ||
| $789.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $19.06M | ||
| $12.59M | ||
| $193.00K | ||
| $0.00 | ||
| $193.00K | ||
| $0.00 | ||
| $3.18M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$8.41M | ||
| $105.82M | ||
| -$52.04M | ||
| $18.00K | ||
| -$8.43M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | ||
| HC Wainwright & Co. | ||
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| Canaccord Genuity | → | |
| Aegis Capital | ||
| Cantor Fitzgerald | ||
| HC Wainwright & Co. | ||
| HC Wainwright & Co. | ||
| Aegis Capital |
Analyst sentiment
Institutional ownership
Screeners with ORMP
FAQ
What is the ticker symbol for Oramed Pharmaceuticals Inc.?
The ticker symbol for Oramed Pharmaceuticals Inc. is NASDAQ:ORMP
Does Oramed Pharmaceuticals Inc. pay dividends?
Yes, Oramed Pharmaceuticals Inc. pays dividends. The last payment was $0.25, with an ex-dividend date on January 16, 2026
What sector is Oramed Pharmaceuticals Inc. in?
Oramed Pharmaceuticals Inc. is in the Healthcare sector
What industry is Oramed Pharmaceuticals Inc. in?
Oramed Pharmaceuticals Inc. is in the Biotechnology industry
What country is Oramed Pharmaceuticals Inc. based in?
Oramed Pharmaceuticals Inc. is headquartered in United States
When did Oramed Pharmaceuticals Inc. go public?
Oramed Pharmaceuticals Inc. initial public offering (IPO) was on May 1, 2007
Is Oramed Pharmaceuticals Inc. in the S&P 500?
No, Oramed Pharmaceuticals Inc. is not included in the S&P 500 index
Is Oramed Pharmaceuticals Inc. in the NASDAQ 100?
No, Oramed Pharmaceuticals Inc. is not included in the NASDAQ 100 index
Is Oramed Pharmaceuticals Inc. in the Dow Jones?
No, Oramed Pharmaceuticals Inc. is not included in the Dow Jones index
When was Oramed Pharmaceuticals Inc. last earnings report?
Oramed Pharmaceuticals Inc.'s most recent earnings report was on November 13, 2025
When does Oramed Pharmaceuticals Inc. report earnings?
The next expected earnings date for Oramed Pharmaceuticals Inc. is March 31, 2026
Data Sources & References
- ORMP Official Website www.oramed.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1176309/000101376225003450/0001013762-25-003450-index.htm
- ORMP Profile on Yahoo Finance finance.yahoo.com/quote/ORMP
- ORMP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ormp